Empowered Funds, LLC
Position in PTGX — Protagonist Therapeutics, Inc
CIK 1592828
NEWTOWN SQUARE, PA
Position in PTGX
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$277,521
+$32,888 QoQ
Shares Held
2,264
-2.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#250
of 341 holders
Holding Since
Mar 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Empowered Funds, LLC holds $300,617,707 across 58 Biotechnology names. PTGX ranks #43 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
187,271 | $49,948,919 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
106,854 | $25,748,605 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
50,197 | $24,934,353 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
33,963 | $21,177,286 | |
| 5 | INCY |
Incyte Corp
|
174,884 | $19,824,845 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
223,142 | $17,692,927 | |
| 7 | EXEL |
Exelixis, Inc.
|
272,490 | $14,826,178 | |
| 8 | ANAB |
Anaptysbio, Inc
|
206,010 | $13,905,675 |
All Filings in PTGX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $277,521 | 2,264 | Shares | Other | 2026-08-17 | |
| 2026-03-31 | $244,633 | 2,321 | Shares | Other | 2026-05-15 | |
| 2025-03-31 | $4,958,447 | 102,532 | Shares | Other | 2025-05-16 | |
| No filing history on record for this holder in this stock. | ||||||